Standout Papers
Immediate Impact
1 by Nobel laureates 13 from Science/Nature 100 standout
Citing Papers
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
2020 Standout
The challenge of antimicrobial resistance: What economics can contribute
2019 StandoutScience
Works of Joel Lexchin being referenced
The cost of drug development: A systematic review
2011
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joel Lexchin | 3678 | 3350 | 1596 | 264 | 8.2k | |
| Eric G. Campbell | 1951 | 1262 | 2243 | 158 | 8.4k | |
| Jerome P. Kassirer | 1682 | 722 | 1400 | 167 | 8.4k | |
| David Blumenthal | 3970 | 1436 | 2711 | 185 | 13.8k | |
| Aaron S. Kesselheim | 7357 | 2198 | 1679 | 707 | 14.2k | |
| Richard L. Kravitz | 3296 | 1454 | 3021 | 282 | 17.4k | |
| Lisa M. Schwartz | 1567 | 655 | 1232 | 127 | 9.9k | |
| Steven Woloshin | 1537 | 575 | 1199 | 137 | 9.4k | |
| Lisa Bero | 3645 | 3095 | 4453 | 318 | 17.4k | |
| Barbara Mintzes | 1123 | 1372 | 789 | 113 | 3.5k | |
| Jeffrey K Aronson | 1293 | 861 | 939 | 317 | 10.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...